Is Jubilant Ingrevia (JUBLINGREA) overvalued or fairly valued?

MarketChacha shows Jubilant Ingrevia's valuation in context — a forward P/E of about 20.8, a price-to-book of about 3.2 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is Jubilant Ingrevia's revenue?

Jubilant Ingrevia reported revenue of ₹4,138 Cr for FY2026, with net profit of ₹268 Cr, per official filings.

What is the share price of Jubilant Ingrevia (JUBLINGREA)?

Jubilant Ingrevia last traded at ₹623.70 (-1.1% on the day), as of 10/19/2026 — a delayed quote shown for education, not investment advice.

Jubilant Ingrevia

JUBLINGREA · NSE · Chemicals · India

Snapshot

TickerJUBLINGREA

ExchangeNSE

SectorChemicals

IndustrySpecialty Chemicals

CountryIndia

Employees2,185

HeadquartersNoida, India

Websitejubilantingrevia.com

Filings tracked8

About Jubilant Ingrevia

Jubilant Ingrevia Limited engages in life science products and solutions in India, the United States, Europe, China and internationally. It operates in three segments, Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing services, and microbial control solutions. The Nutrition & Health Solutions segment provides nutrition and health ingredients; and animal and human nutrition health solutions. The Chemical intermediates segment offers acetyls and specialty ethanol, such as acetic anhydride, bio acetic acid, bio-acetaldehyde, ethyl acetate, propionic anhydride, and formaldehyde. The company also provides vitamins, mineral premixes, stress regulator, amino acid, herbal choline, herbal non-antibiotic growth promoter and egg quality enhancer, toxin binder, acidifiers, and enzymes and emulsifiers. It serves pharmaceutical, nutrition, agrochemical, personal care, semiconductor, and industrial sectors. The company was formerly known as Jubilant LSI Limited and changed its name to Jubilant Ingrevia Limited in October 2020. Jubilant Ingrevia Limited was incorporated in 2019 and is headquartered in Noida, India.

Who owns it

Promoters50.9%
Institutions28.2%
Public & other20.9%

48 institutional holders

Ownership breakdown from public market data. Promoter pledge is not included here — that comes from exchange shareholding filings.

Forensic scorecard

No major accounting red flags in the fundamentals we have — profit is backed by cash and returns look healthy.

Net margin trend6.4% → 6.3%

Margin has held broadly steady over the period — stable profitability.

Growth qualityrev -2% · PAT -2%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (Yahoo Finance). Education, not a rating or recommendation.

What's expected next

Next fiscal year

Rev ₹5,870 Cr · EPS 29.96

Est. earnings growth +16.4%

Analyst consensus estimates — not the company's own guidance.

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: Yahoo Finance

Annual

Quarterly · last 4

Revenue (FY2026)

₹4,388 Cr

Net margin

6.3%

Revenue CAGR (3y)

-2.8%

Profit CAGR (3y)

-3.3%

Net profit (FY2026)

₹278 Cr

Ask MarketChacha about JUBLINGREA

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	Net margin
FY2026	₹4,388 Cr	₹278 Cr	6.3%
FY2025	₹4,178 Cr	₹251 Cr	6.0%
FY2024	₹4,136 Cr	₹183 Cr	4.4%
FY2023	₹4,773 Cr	₹308 Cr	6.4%

Quarterly

Period	Revenue	Net profit	Net margin
Q1 FY27	₹1,300 Cr	₹106 Cr	8.1%
Q4 FY26	₹1,179 Cr	₹86 Cr	7.3%
Q3 FY26	₹1,051 Cr	₹47 Cr	4.5%
Q2 FY26	₹1,121 Cr	₹69 Cr	6.2%

Figures as reported, in ₹ (crore). Source: Yahoo Finance.

Filings & announcements

2026

Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Scrutinizer Report along with Voting Results of the 7th AGM
BSE8/26/2026material
Shareholder Meeting / Postal Ballot-Outcome of AGM
Outcomes of AGM
BSE8/26/2026material
Press Release / Media Release
Press Release
BSE8/18/2026
Acquisition
The Board approved to enter into binding term sheet with Zettaone Technologies India Private Limited (Zettaone) for acquisition of 40% strategic equity stake in Zettaone.
BSE8/18/2026material
Intimation Regarding Letter Dispatched To The Shareholders Of The Company For Annual Report Of The Company For FY 2025-26
Letter sent to the shareholders whose e-mails are not registered
BSE8/1/2026
Business Responsibility and Sustainability Reporting (BRSR)
Business Responsibility and Sustainability Report of the Company for the Financial Year 2025-26
BSE8/1/2026
Reg. 34 (1) Annual Report.
Annual Report of the Company for the Financial Year ended 2025-26
BSE8/1/2026
Earnings Call Transcript
Transcript of Investors'' Conference Call for the Quarter ended June 30, 2026
BSE7/27/2026

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.